- Dexcom Reports First Quarter 2024 Financial Results
- Dexcom Publishes Annual Sustainability Report
- Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
- Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
- Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD
- Dexcom Announces Upcoming Conference Presentation
- Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results
- Dexcom Launches Dexcom One+ Bringing Powerful, New Diabetes Management Technology to More People
More ▼
Key statistics
On Wednesday, Dexcom Inc (DXCM:NSQ) closed at 125.88, -11.35% below its 52-week high of 142.00, set on Mar 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 126.21 |
---|---|
High | 128.74 |
Low | 123.52 |
Bid | 125.50 |
Offer | 128.75 |
Previous close | 125.88 |
Average volume | 3.49m |
---|---|
Shares outstanding | 397.68m |
Free float | 396.26m |
P/E (TTM) | 82.97 |
Market cap | 50.06bn USD |
EPS (TTM) | 1.52 USD |
Data delayed at least 15 minutes, as of May 01 2024 21:15 BST.
More ▼